Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp66 | Bone development/growth and fracture repair | ECTS2013

The P2Y2 receptor restrains BMD during development

Syberg Susanne , Ellegaard Maria , Schwarz Peter , Jorgensen Niklas Rye

The P2Y2 receptor is a G-protein-coupled receptor and the natural ligands (ATP/UTP) strongly inhibit mineralized bone nodule formation by osteoblasts in vitro. We have earlier shown that overexpression of the P2Y2 receptor in vivo resulted in decreased bone mineral density (BMD), partially due to increased bone resorption, but also decreased formation (detected by serum bone markers and bone histomorphometry).This ...

ba0001pp285 | Muscle, physical activity and bone | ECTS2013

Prolonged botulinum toxin type A-induced muscle paralysis results in loss of bone mineral density and bone strength in young female rats

Ellegaard Maria , Syberg Susanne , Jorgensen Niklas Rye , Schwarz Peter

Transient paralysis by a single injection of botulinum toxin type A (Botox) in rodents has been shown to cause local bone loss of the affected leg. The animals regain function of the leg within 3–4 weeks and bone loss slowly recovers. The duration of the paralysis is dose-dependent. However, higher doses of Botox cause weight loss and decreased activity level.Aim of study was to investigate whether repeated injections of low-dose Botox could induce ...

ba0001pp388 | Osteoporosis: pathophysiology and epidemiology | ECTS2013

The association of leptin: adiponectin ratio with bone in overweight and obese postmenopausal women

Chi Yi-Chih , Liu Pei-Yang , Spicer Maria , Ilich Jasminka

Leptin and adiponectin have an opposing relationship in circulation; leptin is higher and adiponectin lower in overweight/obese individuals, and vice versa. Studies showed that both leptin and adiponectin can be either beneficial or harmful to bone depending on the mode of action. The objective was to investigate the association of serum leptin:adiponectin ratio (L:A) with BMD of various skeletal sites and markers of bone turnover in overweight and obese postmenopausa...

ba0001pp389 | Osteoporosis: pathophysiology and epidemiology | ECTS2013

Serum leptin and adiponectin in overweight and obese postmenopausal women after the 6-month weight loss program and their relationship with BMD

Chi Yi-Chih , Liu Pei-Yang , Spicer Maria , Ilich Jasminka

The connection between osteoporosis and obesity is becoming a topic of increasing research. The adipocyte-secreted hormones, leptin and adiponectin, may be the mediators between adipose tissue and bone. The aim was to examine the changes in leptin and adiponectin with the weight and body composition (fat and lean mass) change during the 6-months weight loss program. Additionally, the relationship between two adipokines and BMD of various skeletal sites was also examined. Parti...

ba0001pp480 | Other diseases of bone and mineral metabolism | ECTS2013

Effect of polyphenolic compounds from Aronia melanocarpa berries on cadmium accumulation in the bone tissue

Brzoska Malgorzata M , Galazyn-Sidorczuk Malgorzata , Jurczuk Maria

Cadmium (Cd) is a toxic heavy metal characterized by strong cumulative properties in the human and animals’ organism. Although cadmium accumulation in the bone tissue is lower than in soft tissues such as liver and kidney, the bone-accumulated metal, even at low concentrations, can damage the bone tissue directly. Polyphenols are compounds possessing hydroxyl groups capable of binding divalent metals, including toxic metals, preventing their absorption from the gastrointe...

ba0002p6 | (1) | ICCBH2013

The relationship between bone health and body composition profile in patients with galactose metabolic disorders: implications for practice

Doulgeraki Artemis , Monopolis Ioannis , Deligianni Domna , Kalogerakou Maria , Schulpis Kleopatra

Objectives: To evaluate bone health and its possible correlations to body composition parameters in young patients with galactose metabolic disorders, aiming to suggest appropriate lifestyle interventions.Methods: We studied 22 patients, aged 5–16 years with galactose metabolic disorders, detected by neonatal screening. Fourteen suffered from classic galactosemia and eight from other galactose metabolic disorders (i.e. epimerase or galactokinase def...

ba0002p69 | (1) | ICCBH2013

sRANKL/OPG in children with idiopathic hypercalciuria

Pavlou Maria , Siomou Ekaterini , Cholevas Vasileios , Siamopoulou Antigone , Challa Anna

Objectives: To determine any relationship of serum concentrations of osteoprotegerin (OPG), sRANKL and sRANKL:OPG ratio with idiopathic hypercalciuria (IH) in children, as there is some evidence of increased bone resorption in these patients.Methods: In a prospective study, twenty four children of median age 6.5 years (range 2.3–16.4) with IH (five had urolithiasis and two nephrocalcinosis) were examined at the time of diagnosis and after 3 months o...

ba0002p113 | (1) | ICCBH2013

Everyday chemicals modulate bone properties during development

Herlin Maria , Bjorkeson Ewa , Bowers Wayne J , Hakansson Helen

Objectives: In the modern society, all individuals are exposed throughout life to a variety of chemicals, which may contribute significantly to the human disease burden. Most of these chemicals are transferred to the fetus in-utero and to the infant via mother’s milk. Until recently, few studies have addressed effects of chemicals on the development of mineralized tissues following exposure during these early stages of life. In this experimental study, we analyse...

ba0003pp148 | Cell biology: osteoblasts and bone formation | ECTS2014

Expression of BDNF gene in the femur of aged vs adult rats

Camerino Claudia , Cannone Maria , Heiny Judy , Tricarico Domenico

Brain-derived neurotrophic factor (BDNF) has recently emerged as a factor able to concurrently target age related diseases as neurodegenerative disease, osteoporosis and metabolic syndrome. However the role of BDNF in the frailty syndrome associated with aging has never been investigated. The deletion of central BDNF gene in mice results in increased bone mass and in vitro experiments show that BDNF has a positive effect on bone. BDNF expression is mediated by estroge...

ba0003pp193 | Genetics | ECTS2014

MK-7 enhances expression of genes related to bone, enamel and dentin, and reduces the expression of genes related to apoptosis in developing murine molars

Landin Maria A. , Shabestari Yashar , Sehic Amer , Osmundsen Harald

Introduction: The fat-soluble and vitamin K2 homologe Menaquinone-7 (MK-7) is needed for post-translational modification of proteins essential in blood coagulation, and in metabolic pathways in various tissues like bone. Recent studies found an association between long-term anticoagulant treatment (OAC) and reduced bone quality due to reduction of active osteocalcin. OAC is often linked to an undesired soft-tissue calcification in both children and adults and may lead to incre...